You just read:

U.S. FDA Acknowledges Receipt of Evofem Biosciences' New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy

News provided by

Evofem Biosciences, Inc.

Dec 18, 2019, 07:30 ET